Summary
In 43 patients with inoperable bronchogenic carcinoma — 32 small cell and 11 squamous or large cell — Angiotensin-Converting-Enzyme (ACE) activity in serum was determined before and every 3–5 weeks during cytotoxic chemotherapy. ACE-activity prior to therapy was 10.7 U ± 1.17 SE as compared to the normal values 20.4 U ± 1.8 SE which was statistically significant (p<0.01). There was no significant difference between the basal values of patients with small cell and not small cell-carcinoma of the lung. Only for patients with small cell-carcinoma of the lung a significant rise in ACE-activity could be obtained. Mean values of these patients reached normal levels in case they had complete remission, which was achieved in the limited disease group in 82% of patients.
The present data suggest, that ACE-activities in serum correspond well to the clinical course in patients with small cell carcinoma of the lung. The decision on the individual mode of therapy may thus become more substantiated by serial determinations of ACE in the course of treatment.
Similar content being viewed by others
Literatur
Ashutosh K, Keighley JFH (1976) Diagnostic value of serum angiotensin converting enzyme activity in lung disease. Thorax 31:552–557
Bedrossian CWM, Woo J, Miller WC, Cannon DC (1978) Decreased angiotensin converting enzyme in the adult respiratory distress syndrome. Am J Clin Pathol 70:244–247
DeRemee RA, Rohrbach MS (1980) Serum angiotensin converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Int Med 92:361–365
Grönhagen-Riska G (1980) Angiotensin converting enzyme: Activity and correlation with serum lysozyme in sarcoidosis, other chest or lymph node diseases and healthy persons. Scand J Resp Dis 60:83–89
Heck I, Spilker G, Niederle N, Bierbaum W, Stumpe K, Krück F (1980) Veränderungen der Converting-Enzym-Aktivität bei lungenverkleinernden Eingriffen und beim Bronchialkarzinom. Verh Dtsch Ges Inn Med 86:1149–1152
Heck I, Hack G, Fricke G, Kirchhoff PG, Krück F (1982) Bedeutung des Lungenkreislaufs für die Konversion von Angiotensin I in Angiotensin II — Untersuchungen unter cardiopulmonalem Bypass. 50. Jahresversammlung der Schweiz Ges Inn Med
Hollinger MA, Giri SN, Patwell S, Zuckerman JE, Gorin A, Parsons G (1980) Effect of acute lung injury on angiotensin converting enzyme in serum, lung lavage and effusate. Am Rev Resp Dis 121:373–376
Johnson AR (1980) Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins. J Clin Invest 65:841–850
Leuenberger PJ, Stalcup SA, Mellins RB, Greenbaum LM, Turino GM (1978) Decrease in angiotensin I conversion by acute hypoxia in dogs (40252). Proc Soc Exp Biol Med 158:586–589
Lieberman J (1975) Elevation of serum angiotensin converting enzyme (ACE) level in sarcoidosis. Am J Med 59:365–372
Lieberman J, Beutler E (1976) Elevation of serum angiotensin converting enzyme in gaucher's disease. N Engl J Med 294:1442–1444
Meyer DK, Liebig R, Abele M, Jobke A, Hertting G (1976) Conversion of angiotensin I in isolated perfused guinea pig and rat lung. Naunyn-Schmiedeberg's Arch Pharmacol 292:183–187
Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214
Mue S, Takahashi M, Ohmi T, Shibahara S, Yamauchi K, Fujimoto S, Okayama H, Takishima T (1978) Serum angiotensin converting enzyme level in bronchial asthma. Ann Allerg 40:51–57
Ng KKF, Vane JR (1968) Fate of angiotensin I in the circulation. Nature 218:144–150
Niederle N, Krischke W, Schulz U, Schmidt CG, Seeber S (1982) Untersuchungen zur kurzzeitigen Induktions- und zyklischen Erhaltungstherapie beim inoperablen Bronchialkarzinom. Klin Wochenschr 60:829–838
Niederle N, Krischke W, Roer N, Seeber S, Schmidt CG (1982) Erste Ergebnisse einer zytostatischen Kombinations-Chemotherapie beim nichtkleinzelligen Bronchialkarzinom. Verh Dtsch Ges Inn Med 88:436–438
Nosal A, Schleissner LA, Mishkin FS, Lieberman J (1979) Angiotensin I converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. Ann Int Med 90:328–331
Odya CE, Hall ER, Robinson CJG (1979) Radioimmunoassay for pig angiotensin I converting enzyme: A comparison of immunologic with enzymatic activity. Biochem Biophys Res Comm 86:508–513
Oparil S, Low J, Koerner TJ (1976) Altered angiotensin I conversion in pulmonary disease. Clin Sci Mol Med 51:537–543
Rohatgi PK, Ryan JW, Lindeman P (1981) Value of serial measurement of serum angiotensin converting enzyme in the management of sarcoidosis. Am J Med 70:44–50
Rømer FK, Emmertsen K (1980) Serum angiotensin converting enzyme in malignant lymphomas, leukaemia and multiple myeloma. Br J Cancer 42:314–318
Rømer FK (1981) Angiotensin converting enzyme and its associations with outcome in lung cancer. Br J Cancer 43:135–142
Ryan JW, Ryan VS, Schultz DR, Whitaker G, Chung A (1975) Subcellular localization of pulmonary angiotensin converting enzyme (kinase II). Biochem 146:497–499
Sachs L (1974) Angewandte Statistik. Springer, Berlin Heidelberg New York
Silverstein E, Friedland J, Lyons HA (1977) Serum angiotensin converting enzyme in sarcoidosis: clinical significance. Isr Med Sci 13:1001–1006
Silverstein E, Pertschuk LP, Friedland J (1979) Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. Proc Natl Acad Sci 76:6646–6648
Soffer RL (1976) Angiotensin converting enzyme and the regulation of vasoactive peptides. Ann Rev Biochem 45:73–94
Spech HJ, Wernze H, Weiss H (1976) Radioimmunoassay of angiotensin II and its metabolities. Comparison of two different extraction procedures. Acta Endocrinol (Kbh) [Suppl] 202:67–69
Stalcup SA, Lipset JS, Woan JM, Leuenberger P, Mellins RB (1979) Inhibition of angiotensin converting enzyme activity in cultured endothelial cells by hypoxia. J Clin Invest 63:966–976
Turton CWG, Grundy E, Firth G, Mitchell D, Rigden BG, Turner-Warwick M (1979) Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis. Thorax 34:57–62
Author information
Authors and Affiliations
Additional information
Herrn Prof. Dr. F. Krück zum 62. Geburtstag gewidmet
Rights and permissions
About this article
Cite this article
Heck, I., Niederle, N. Angiotensin-Converting-Enzym-Aktivität während zytostatischer Therapie bei Patienten mit primär inoperablem Bronchialkarzinom. Klin Wochenschr 61, 923–927 (1983). https://doi.org/10.1007/BF01537533
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01537533